| __timestamp | Alpine Immune Sciences, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 26684000 |
| Thursday, January 1, 2015 | 6844000 | 29829000 |
| Friday, January 1, 2016 | 8586000 | 39578000 |
| Sunday, January 1, 2017 | 6079000 | 43277000 |
| Monday, January 1, 2018 | 8362000 | 48645000 |
| Tuesday, January 1, 2019 | 9467000 | 52934000 |
| Wednesday, January 1, 2020 | 10899000 | 61349000 |
| Friday, January 1, 2021 | 14560000 | 127125000 |
| Saturday, January 1, 2022 | 17968000 | 136106000 |
| Sunday, January 1, 2023 | 22222000 | 133175999 |
Cracking the code
In the ever-evolving landscape of biotechnology, operational efficiency is paramount. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited, from 2014 to 2023. Over this period, HUTCHMED consistently outpaced Alpine in SG&A spending, with a peak in 2022 where its expenses were approximately six times higher than Alpine's. Notably, Alpine's SG&A expenses grew nearly tenfold, from $2.3 million in 2014 to $22.2 million in 2023, reflecting its strategic expansion efforts. Meanwhile, HUTCHMED's expenses surged from $26.7 million to $133.2 million, underscoring its aggressive market positioning. This financial trajectory highlights the contrasting growth strategies of these companies, offering insights into their operational priorities and market ambitions.
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and HUTCHMED (China) Limited
Who Optimizes SG&A Costs Better? Sanofi or Alpine Immune Sciences, Inc.
Takeda Pharmaceutical Company Limited and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Summit Therapeutics Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
Opthea Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Veracyte, Inc.
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Novavax, Inc.
Comparing SG&A Expenses: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for HUTCHMED (China) Limited and Soleno Therapeutics, Inc.
HUTCHMED (China) Limited or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?